The miR-181 family regulates differentiation via BCL-2, HOXA9, and MEIS1 and shows context-dependent roles-upregulated in favorable AML but decreased in high-risk MDS and secondary AML, and in some settings associated with increased chemosensitivity [13,14,15]. This evidence concerns the gene MEIS1 and myelodysplastic syndrome.